202 related articles for article (PubMed ID: 24526405)
1. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
Schempf U; Sipos B; König C; Malek NP; Bitzer M; Plentz RR
Z Gastroenterol; 2014 Feb; 52(2):200-3. PubMed ID: 24526405
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature.
Callata-Carhuapoma HR; Pato Cour E; Garcia-Paredes B; Fernandez RM; Mendoza Fernandez ML; Fernandez AM; De La Rosa CA; Sotelo Lezama MJ; Cabezas-Camarero S; Sastre Varela J
Pancreatology; 2015; 15(4):440-4. PubMed ID: 25959244
[TBL] [Abstract][Full Text] [Related]
3. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
[TBL] [Abstract][Full Text] [Related]
5. A R0 resection case of initially unresectable metastatic pancreatic cancer downstaged by FOLFIRINOX therapy.
Sasaki T; Isayama H; Aoki T; Tanaka M; Hamada T; Nakai Y; Sakamoto Y; Hasegawa K; Morikawa T; Fukayama M; Kokudo N; Koike K
Pancreas; 2014 Aug; 43(6):972-4. PubMed ID: 25010709
[No Abstract] [Full Text] [Related]
6. Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months.
Shinagare AB; Ramaiya NH; Bellizzi AM; Mayer RJ
Pancreatology; 2012; 12(1):35-8. PubMed ID: 22487471
[TBL] [Abstract][Full Text] [Related]
7. [A case of liver metastasis of mixed acinar-endocrine carcinoma treated with various loco-regional cancer therapies].
Nishii T; Amano R; Nakao S; Doi Y; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2126-8. PubMed ID: 19106545
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Treatment With FOLFIRINOX and Successful Resection for a Patient With Mixed Acinar-Endocrine Carcinoma of the Pancreas.
Sugimoto M; Hines OJ; Dawson DW; Muthusamy VR; Reber HA; Donahue TR
Pancreas; 2017 Apr; 46(4):e32-e34. PubMed ID: 28291165
[No Abstract] [Full Text] [Related]
9. Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma.
Byrne JD; Jajja MR; Schorzman AN; Keeler AW; Luft JC; Zamboni WC; DeSimone JM; Yeh JJ
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2200-5. PubMed ID: 26858448
[TBL] [Abstract][Full Text] [Related]
10. A case report of a patient with advanced acinar cell carcinoma of the pancreas: long-term survival with regional, systemic and targeted therapy.
Ang C; Herran LA; Lagunes DR; Klimstra DS; Kemeny NE
Tumori; 2013; 99(2):e61-4. PubMed ID: 23748831
[TBL] [Abstract][Full Text] [Related]
11. Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Hohla F; Hopfinger G; Romeder F; Rinnerthaler G; Bezan A; Stättner S; Hauser-Kronberger C; Ulmer H; Greil R
Int J Oncol; 2014 Jan; 44(1):319-26. PubMed ID: 24247204
[TBL] [Abstract][Full Text] [Related]
12. Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: A case report.
Uemura S; Maeda H; Tanioka N; Yamaguchi S; Munekage M; Kitagawa H; Namikawa T; Yamamoto S; Kohsaki T; Iguchi M; Uchida K; Hanazaki K
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1648. PubMed ID: 35668046
[TBL] [Abstract][Full Text] [Related]
13. Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.
Zhu J; Strosberg JR; Dropkin E; Strickler JH
J Gastrointest Cancer; 2015 Jun; 46(2):166-9. PubMed ID: 25662891
[No Abstract] [Full Text] [Related]
14. FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experience.
Moorcraft SY; Khan K; Peckitt C; Watkins D; Rao S; Cunningham D; Chau I
Clin Colorectal Cancer; 2014 Dec; 13(4):232-8. PubMed ID: 25442814
[TBL] [Abstract][Full Text] [Related]
15. Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy.
Distler M; Rückert F; Dittert DD; Stroszczynski C; Dobrowolski F; Kersting S; Grützmann R
World J Surg Oncol; 2009 Feb; 7():22. PubMed ID: 19239719
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.
Tinchon C; Hubmann E; Pichler A; Keil F; Pichler M; Rabl H; Uggowitzer M; Jilek K; Leitner G; Bauernhofer T
Acta Oncol; 2013 Aug; 52(6):1231-3. PubMed ID: 23445338
[No Abstract] [Full Text] [Related]
17. FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.
Levy A; Chargari C; Huguet F; Védrine L; Deutsch E
Pancreas; 2012 Aug; 41(6):973-4. PubMed ID: 22781912
[No Abstract] [Full Text] [Related]
18. Multifocal anaplastic pancreatic carcinoma requiring neoadjuvant chemotherapy and total pancreatectomy: report of a case.
Jones TS; Jones EL; McManus M; Shah R; Gajdos C
JOP; 2013 May; 14(3):289-91. PubMed ID: 23669483
[TBL] [Abstract][Full Text] [Related]
19. Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.
Mondo EL; Noel MS; Katz AW; Schoeniger LO; Hezel AF
J Clin Oncol; 2013 Jan; 31(3):e37-9. PubMed ID: 23233707
[No Abstract] [Full Text] [Related]
20. Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: report of a case.
Turner K; Levi Sandri GB; Boucher E; Hénno S; Le Prisé E; Meunier B; Boudjema K; Sulpice L
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e29-31. PubMed ID: 25288453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
